Centre places 'Covishield' purchase order with Serum Institute for 11 million doses at Rs 200 each
Pune: The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca COVID-19 vaccine.
"We have received the (purchase) order from the Government of India on Monday afternoon," a senior SII official told PTI.
Centre has placed purchase order with Serum Institute for 11 million doses of Covishield vaccine each costing Rs 200.
The government has already announced that the process of administering the vaccine will start on on January 16.
The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.